100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
Previously searched by you
A patient with AIDS has developed a number of secondary infections in recent weeks, including Kaposi's sarcoma. As a result of this most recent diagnosis, his care team has opted to begin treatment with interferon alfa-2a. The nurse is aware that th$9.49
Add to cart
A patient with AIDS has developed a number of secondary infections in recent weeks, including Kaposi's sarcoma. As a result of this most recent diagnosis, his care team has opted to begin treatment with interferon alfa-2a. The nurse is aware that th
61 views 0 purchase
Course
NUR6521
Institution
NUR6521
A patient with AIDS has developed a number of secondary infections in recent weeks, including Kaposi's sarcoma. As a result of this most recent diagnosis, his care team has opted to begin treatment with interferon alfa-2a. The nurse is aware that this drug will address the etiology of Kaposi sarcom...
Question 1
1 out of 1 points
A patient with AIDS has developed a number of secondary infections in recent weeks,
including Kaposi's sarcoma. As a result of this most recent diagnosis, his care team has
opted to begin treatment with interferon alfa-2a. The nurse is aware that this drug will
address the etiology of Kaposi sarcoma by
Response Like other cytokines, interferon alfa-2a inhibits the growth of tumor
Feedback cells, prevents these cells from multiplying, and modulates the host
: immune response to help protect the body from tumor cells. This drug does
not increase B-cell and T-cell production, induce mutations, or increase the
effects of phagocytes and macrophages.
Question 2
1 out of 1 points
A 72-year-old patient is prescribed ophthalmic ciprofloxacin for a bacterial infection in her right
eye. The nurse will teach her to observe for which of the following adverse effects of the drug?
Response
Feedback Adverse reactions to ophthalmic ciprofloxacin usually involve local effects
: such as burning or discomfort. Other adverse effects of ophthalmic
ciprofloxacin are lid margin crusting, crystals, scales, foreign body sensation,
pruritus, conjunctival hyperemia, and a bad taste in the mouth. Increased
intracranial pressure and tendon ruptures are not identified adverse effects
of ophthalmic ciprofloxacin. Nephrotoxicity and neurotoxicity are the primary
adverse effects of polymyxin B.
Question 3
1 out of 1 points
A 15-year-old boy is being carefully monitored for a skin infection and is being given
ciprofloxacin. The nurse will observe for which of the following?
Response A serious adverse reaction of ciprofloxacin is arthropathy, or joint pain,
Feedback especially in children. This irreversible adverse reaction tends to occur
: in children under 18 years of age. Colitis is another adverse reaction of
ciprofloxacin that the nurse needs to monitor for, but it generally does not
Page 1 of 14
, affect children under 18 years of age. Hepatitis and hypotension are not
identified adverse effects of ciprofloxacin in children or adults.
Question 4
1 out of 1 points
A patient is to begin taking tobramycin (Nebcin) for a nosocomial infection. Which of the
following assessments should the nurse prioritize?
Response Peak and trough levels should be closely monitored with serious
Feedback infections being treated with tobramycin. The patient's blood pressure,
: diet, weight, and other medications would be important to know and
necessary for the plan of care, but are secondary to serum levels.
Question 5
1 out of 1 points
A patient has endocarditis and is taking gentamicin. The nurse will be sure to monitor which
of the following?
Response Gentamicin is nephrotoxic and can result in acute tubular necrosis. The
Feedback nurse will need to monitor for excessive urea level in the blood,
: decreased creatinine clearance, loss of the ability to concentrate urine,
increased white blood cell count in the urine, and cells or casts in the urine.
Potassium, albumin level, and prothrombin time are not associated with the
adverse effects of gentamicin.
Question 6
1 out of 1 points
Mr. Laird is a 49-year-old electrician who experienced severe burns on his trunk, arms, and
hands in a workplace accident 2 weeks ago. Part of his current wound care regimen involves
the daily application of silver sulfadiazine to his wounds. The nurses who are providing care
for Mr. Laird in the burns and plastics unit of the hospital should perform what action when
administering this medication?
Before applying silver sulfadiazine, it is necessary to cleanse the wound
completely and remove dead or burned skin and other debris. It would be
inappropriate to perform wound care after the application of the drug and it
should be applied in a thin layer no more than about 1/16 inch. Application of
topical sulfonamides is a sterile, not clean, procedure.
Question 7
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller BRADFORD. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $9.49. You're not tied to anything after your purchase.